Journal Information

Special content about coronavirus SARS-CoV-2 (COVID-19) in Actas Dermo-Sifiliográficas

[Translated article] Nuclear Factor Erythroid 2-Related Factor 2 in Vitiligo
V. Romano-Lozano, A. Cruz-Avelar, M.L. Peralta-Pedrero
10.1016/j.ad.2022.06.002
Actas Dermosifiliogr. 2022;113:T705-11
Open access
[Translated article] Facial Vitiligo After SARS-CoV-2 Vaccination
M.Á. Flores-Terry, M. García-Arpa, J.L. Santiago-Sánchez Mateo, G. Romero Aguilera
10.1016/j.ad.2022.06.012
Actas Dermosifiliogr. 2022;113:T721
Open access
[Translated article] Psoriasis While Home Isolation Policies to Contain COVID-19 Were in Effect: A Follow-Up Survey of Patients Treated at an Argentine Hospital
G.G. Mangiarotti, C.M. Arias, E. Zak, G.A. Castro Pérez
10.1016/j.ad.2022.01.041
Actas Dermosifiliogr. 2022;113:T745-7
Open access
Use of Cyclosporine Therapy in Dermatology During COVID-19 Pandemic
Y.S. Pathania
10.1016/j.ad.2021.10.009
Actas Dermosifiliogr. 2022;113:657-8
Open access
Factor nuclear eritroide similar al factor 2 en el vitíligo
V. Romano-Lozano, A. Cruz-Avelar, M.L. Peralta Pedrero
10.1016/j.ad.2022.02.025
Actas Dermosifiliogr. 2022;113:705-11
Open access
Lesiones faciales de vitíligo tras la administración de la vacuna frente a SARS-CoV-2
M.Á. Flores-Terry, M. García-Arpa, J.L. Santiago-Sánchez Mateo, G. Romero Aguilera
10.1016/j.ad.2022.01.030
Actas Dermosifiliogr. 2022;113:721
Open access
Actualización práctica de las recomendaciones del Grupo de Psoriasis de la Academia Española de Dermatología y Venereología (GPS) para el tratamiento de la psoriasis con terapia biológica. Parte 2 «Manejo de poblaciones especiales, pacientes con comorbilidad y gestión del riesgo»
J.M. Carrascosa, L. Puig, I.B. Romero, L. Salgado-Boquete, E. del Alcázar, J.J.A. Lencina, D. Moreno, P. de la Cueva
10.1016/j.ad.2022.01.024
Actas Dermosifiliogr. 2022;113:583-609
Open access
[Translated article] Practical Update of the Guidelines Published by the Psoriasis Group of the Spanish Academy of Dermatology and Venereology (GPs) on the Treatment of Psoriasis With Biologic Agents: Part 2—Management of Special Populations, Patients With Comorbid Conditions, and Risk
J.M. Carrascosa, L. Puig, I.B. Romero, L. Salgado-Boquete, E. del Alcázar, J.J.A. Lencina, D. Moreno, P. de la Cueva
10.1016/j.ad.2022.01.040
Actas Dermosifiliogr. 2022;113:T583-609
Open access
FR - Epidemia de sarna en el contexto de la pandemia de COVID-19
P.A. Cerro, A. Navarro-Bielsa, A.M. Palma
10.1016/j.ad.2020.11.028
Actas Dermosifiliogr. 2022;113:516-8
Open access
[Translated article] RF - Scabies Outbreak During the COVID-19 Lockdown
P.A. Cerro, A. Navarro-Bielsa, A.M. Palma
10.1016/j.ad.2020.11.037
Actas Dermosifiliogr. 2022;113:T516-8
Open access
Idiomas
Actas Dermo-Sifiliográficas
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?